Hybrid Laboratories India Private Limited

Hybrid Laboratories India Private Limited - healthcare in Amritsar, Punjab, India. FY 2026 financials & compliance.
CIN U52100PB2019PTC050478 Incorporated 24 December 2019 ROC Chandigarh HQ Amritsar, Punjab, India
Active Private Limited Company healthcare
Revenue · FY 2024
₹4.9 Cr
▼ 2% YoY
Net profit · FY 2024
₹5.64 Lakh
Net margin 1.2%
EBITDA · FY 2024
₹15.93 Lakh
EBITDA margin 3.3%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Hybrid Laboratories India Private Limited

Data last updated:

Hybrid Laboratories India Private Limited is a private limited company based in Amritsar, Punjab, India. It operates in the preventive health supplements segment of the healthcare sector. It was incorporated on 24 December 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U52100PB2019PTC050478. Its GSTIN is 03AAFCH1530A1ZJ (Punjab).

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Harneet Singh Luthra and Surinder Kaur Luthra.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 3 35 B Aventura Mall Road, Amritsar, Punjab, India – 143001.

As per the financials filed for FY 2024, the company reported a revenue of ₹4.9 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹5.64 Lakh (net margin 1.2%) and EBITDA of ₹15.93 Lakh (EBITDA margin 3.3%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years.

Company details

CIN U52100PB2019PTC050478
Registration Number 050478
Incorporation Date 24 December 2019
ROC Chandigarh
Listing Status Unlisted
Company Status Active

Contact details

Hybrid Laboratories India Private Limited's registered office is in Amritsar, Punjab. Its e-mail address is in the company report.

  • Email
  • Registered Address
    SCO 3 35 B Aventura Mall Road, Amritsar, Punjab, India – 143001
  • Industry
    Healthcare, Preventive Health Supplements

To see the full contact details of Hybrid Laboratories India Private Limited, buy the company report.

Comprehensive company report
Hybrid Laboratories India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Hybrid Laboratories India is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Hybrid Laboratories India Private Limited, buy the company report.

Financials of Hybrid Laboratories India Private Limited

FY 2025 filings available

Hybrid Laboratories India Private Limited reported revenue of ₹4.9 Cr (down 2% YoY) for FY 2024.

Revenue · FY 2024
₹4.9 Cr ▼ 2%
Net profit · FY 2024
₹5.64 Lakh margin 1.2%
EBITDA · FY 2024
₹15.93 Lakh margin 3.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 10%

Revenue fell 2% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹15.93 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.64 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3.3%
Net Profit Margin1.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Hybrid Laboratories India Private Limited, buy the company report.

Board of directors of Hybrid Laboratories India Private Limited

Hybrid Laboratories India has 2 directors on record. No former directors are listed.

Current Directors

MSME payment delays

No delayed payments to MSME suppliers are on our record for Hybrid Laboratories India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Hybrid Laboratories India has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
03AAFCH1530A1ZJPunjabActive18 Feb 2020

To see the full GST registrations and return filing status of Hybrid Laboratories India Private Limited, buy the company report.

Recent activity

Hybrid Laboratories India Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Harneet Singh Luthra was appointed as Director on 24 Dec 2019.

AGM
Hybrid Laboratories India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hybrid Laboratories India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Appointed
Harneet Singh Luthra was appointed as Director.
Appointed
Surinder Kaur Luthra was appointed as Director.
Incorporation
24 Dec 2019
Hybrid Laboratories India Private Limited was registered on 24 Dec 2019 with Roc Chandigarh & aged 6 years 11 months as per MCA records.

Frequently asked questions

Hybrid Laboratories India is an active private limited company based in Amritsar, Punjab, India. The company works in preventive health supplements, within the healthcare industry. It was incorporated on 24 December 2019 (7+ years old) and is registered under CIN U52100PB2019PTC050478.

Hybrid Laboratories India has 2 current directors:

The latest financial statements of Hybrid Laboratories India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Hybrid Laboratories India is 03AAFCH1530A1ZJ, registered in Punjab.

The CIN (Corporate Identification Number) of Hybrid Laboratories India is U52100PB2019PTC050478. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Hybrid Laboratories India was incorporated on 24 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chandigarh.

Harneet Singh Luthra was appointed as Director on 24 Dec 2019. Surinder Kaur Luthra was appointed as Director on 24 Dec 2019.

The registered office of Hybrid Laboratories India is at SCO 3 35 B Aventura Mall Road, Amritsar, Punjab, India – 143001.

Hybrid Laboratories India operates in the healthcare industry, in the preventive health supplements segment.

Hybrid Laboratories India can be reached at its registered office: SCO 3 35 B Aventura Mall Road, Amritsar, Punjab, India – 143001.